The application of 3D printing in the development of RECIST standard for evaluating tumor efficacyOACSTPCD
The application of 3D printing in the development of RECIST standard for evaluating tumor efficacy
Xiaodan Yang;Tao Han;Yue Zhang;Yanming Zhang;Gao Li;Yongye Liu;Zhaozhe Liu;Zhendong Zheng
Department of Oncology,Cancer Center,General Hospital of Northern Theater Command,Shenyang 110840,ChinaDepartment of Oncology,Cancer Center,General Hospital of Northern Theater Command,Shenyang 110840,ChinaOncology Phymatology,Jinzhou Medical University,Jinzhou 121000,ChinaOncology Phymatology,Jinzhou Medical University,Jinzhou 121000,ChinaDepartment of Clinical Pharmacy,Shenyang Pharmaceautical University,Shenyang 110840,ChinaDepartment of Oncology,Cancer Center,General Hospital of Northern Theater Command,Shenyang 110840,ChinaDepartment of Oncology,Cancer Center,General Hospital of Northern Theater Command,Shenyang 110840,ChinaDepartment of Oncology,Cancer Center,General Hospital of Northern Theater Command,Shenyang 110840,China
Three-dimensional(3D) printingRECIST standardchemotherapy
Three-dimensional(3D) printingRECIST standardchemotherapy
《肿瘤学与转化医学(英文)》 2020 (1)
39-42,4
Supported by a grant from the National Natural Science Foundation of China(No.81702622).
评论